GRAS Notice (GRN) No. 726 for Polyphenol Extract from Olive

Total Page:16

File Type:pdf, Size:1020Kb

GRAS Notice (GRN) No. 726 for Polyphenol Extract from Olive GRAS Notice (GRN) No. 726 https://www.fda.gov/Food/IngredientsPackagingLabeling/GRAS/NoticeInventory/default.htm DSM DSM Nutritional Products Regulatory Affairs 45 Waterview Boulevard Parsippany, NJ 07054 United States of America August 15, 2017 Office of Food Additive Safety (HFS-200), Center for Food Safety and Applied Nutrition, Food and Drug Administration, 5001 Campus Drive, College Park, MD 20740. Subject: GRAS Notification - elaVida ™ To whom it may concern: DSM Nutritional Products LLC is submitting for FDA review a GRAS notification. The enclosed document provides notice of a claim that the food ingredient elaVida TM, which is a polyphenol-rich preparation derived from olive fruits, described in the enclosed notification, is exempt from the premarket approval requirement of the Federal Food, Drug, and Cosmetic Act because it has been determined to be generally recognized as safe (GRAS) based on scientific procedures. If you have any questions or require additional information, please do not hesitate to contact the undersigned at your convenience. Sincerely yours, (b) (6) Georges Bergen (Primary Contact) Senior Manager, Regulatory Affairs DSM Nutritional Products LLC Human Nutrition & Health Ph (973) 257-8366 e-mail: [email protected] {R1~~~~~~[Q) AUG ·1 7 2017 OFFI' '=OF fOOD ~.DOI .i-f SAFETY HEALTH • NUTRITION • MATERIALS Summary of Information Supporting the Generally Recognized As Safe (GRAS) Status of elaVida™ (A Polyphenol Preparation From Olive Fruits) for Use as an Ingredient in Selected Foods - Final ­ Prepared for: DSM Nutritional Products, LLC 45 Waterview Boulevard Parsippany, New Jersey 07054 August 15, 2017 Summary of Information Supporting the Generally Recognized As Safe (GRAS) Status of elaVida™ (A Polyphenol Preparation From Olive Fruits) for Use as an Ingredient in Selected Foods Table of Contents Page 1.0 STATEMENTS AND CERTIFICATION .............................................................................7 1.1 Compliance with 21 C.F.R. § 170.30..............................................................................7 1.2 Name and Address of Notifier ........................................................................................7 1.3 Name and Address of Manufacturer ...............................................................................7 1.4 Name and Address of Exclusive Distributor ...................................................................7 1.5 Name of the Notified Substance .....................................................................................8 1.6 Intended Conditions of Use and Technical Effects of the Notified Substance ................8 1.7 Basis for GRAS Determination .......................................................................................8 1.8 Exemption from Premarket Approval ..............................................................................9 1.9 Availability of Information for FDA Review .....................................................................9 1.10 Copying .......................................................................................................................... 9 1.11 Accessibility to Raw Data ...............................................................................................9 1.12 Exemption From Disclosure ...........................................................................................9 1.13 Certification................................................................................................................... 10 2.0 Identity, Method of Manufacture, Specifications, and Physical or Technical Effect 11 2.1 Identity: elaVida™ (A Polyphenol Preparation From Olive Fruits) ................................11 2.2 Manufacturing and Specifications .................................................................................12 2.2.1 Manufacturing ........................................................................................................... 12 2.2.2 Specifications and Analyses .....................................................................................16 2.3 Compositional analysis of elaVida™ ............................................................................18 2.3.1 Methods .................................................................................................................... 18 2.3.2 Analytical results ....................................................................................................... 18 2.3.3 Other phenols ........................................................................................................... 20 2.4 Stability ......................................................................................................................... 23 2 2.5 Acrylamide .................................................................................................................... 23 2.6 Polyaromatic Hydrocarbons .........................................................................................24 2.7 Physical or Technical Effect .........................................................................................25 3.0 Intended Food Uses and Projected Dietary Exposure................................................26 3.1 Proposed food uses......................................................................................................26 3.2 Available data and methods .........................................................................................28 3.2.1 Consumption data .....................................................................................................28 3.2.2 Existing dietary sources ............................................................................................29 Table 3-2: Average hydroxytyrosol concentration of olives and olive oila ............................30 3.2.3 Dietary supplement uses ..........................................................................................30 3.2.4 Analysis.....................................................................................................................32 3.3 Results.......................................................................................................................... 33 3.2.1 Existing Dietary Exposure.........................................................................................33 3.3.2 Proposed uses ..........................................................................................................33 3.3.3 Cumulative estimated intake of hydroxytyrosol .........................................................35 4.0 SELF LIMITING LEVELS OF USE ..................................................................................38 5.0 EXPERIENCE BASED ON COMMON USE IN FOOD BEFORE 1958 ...........................39 5.1 Scientific Procedures ....................................................................................................39 5.2 Natural occurrence and benefit ....................................................................................39 6.0 NARRATIVE SAFETY .....................................................................................................41 6.1 Forms of olive extract or hydroxytyrosol tested for safety ............................................41 6.2 Absorption, Distribution, Metabolism and Excretion (ADME) of polyphenols focused on hydroxytyrosol ......................................................................................................................... 42 6.2.1 Summary of published ADME data of hydroxytyrosol in mammals ..........................42 6.2.2 Potential drug interactions ........................................................................................45 6.2.3 Plasma data from safety studies ...............................................................................45 6.3 Toxicology studies with olive extracts and hydroxytyrosol ...........................................46 6.3.1 Acute toxicity studies ................................................................................................46 6.3.2 Repeat Dose Toxicity................................................................................................48 6.3.3 Pivotal Subchronic Toxicity Studies ..........................................................................52 6.3.4 Genotoxicity / Mutagenicity ...................................................................................67 6.3.5 Carcinogenicity ......................................................................................................... 78 6.3.6 Reproduction Toxicity ...............................................................................................79 3 6.4 Human Safety Data ......................................................................................................83 6.4.1 Human data .............................................................................................................. 83 6.4.2 Olive oil and polyphenol content ...............................................................................84 6.4.3 Olive extracts ............................................................................................................ 84 6.4.4 Pure hydroxytyrosol ..................................................................................................86 6.5 Safety Summary and Acceptable Daily Intake (ADI) ....................................................86 7.0 LIST OF SUPPORTING DATA AND INFORMATION .....................................................88 APPENDIX
Recommended publications
  • Aldrich Raman
    Aldrich Raman Library Listing – 14,033 spectra This library represents the most comprehensive collection of FT-Raman spectral references available. It contains many common chemicals found in the Aldrich Handbook of Fine Chemicals. To create the Aldrich Raman Condensed Phase Library, 14,033 compounds found in the Aldrich Collection of FT-IR Spectra Edition II Library were excited with an Nd:YVO4 laser (1064 nm) using laser powers between 400 - 600 mW, measured at the sample. A Thermo FT-Raman spectrometer (with a Ge detector) was used to collect the Raman spectra. The spectra were saved in Raman Shift format. Aldrich Raman Index Compound Name Index Compound Name 4803 ((1R)-(ENDO,ANTI))-(+)-3- 4246 (+)-3-ISOPROPYL-7A- BROMOCAMPHOR-8- SULFONIC METHYLTETRAHYDRO- ACID, AMMONIUM SALT PYRROLO(2,1-B)OXAZOL-5(6H)- 2207 ((1R)-ENDO)-(+)-3- ONE, BROMOCAMPHOR, 98% 12568 (+)-4-CHOLESTEN-3-ONE, 98% 4804 ((1S)-(ENDO,ANTI))-(-)-3- 3774 (+)-5,6-O-CYCLOHEXYLIDENE-L- BROMOCAMPHOR-8- SULFONIC ASCORBIC ACID, 98% ACID, AMMONIUM SALT 11632 (+)-5-BROMO-2'-DEOXYURIDINE, 2208 ((1S)-ENDO)-(-)-3- 97% BROMOCAMPHOR, 98% 11634 (+)-5-FLUORODEOXYURIDINE, 769 ((1S)-ENDO)-(-)-BORNEOL, 99% 98+% 13454 ((2S,3S)-(+)- 11633 (+)-5-IODO-2'-DEOXYURIDINE, 98% BIS(DIPHENYLPHOSPHINO)- 4228 (+)-6-AMINOPENICILLANIC ACID, BUTANE)(N3-ALLYL)PD(II) CL04, 96% 97 8167 (+)-6-METHOXY-ALPHA-METHYL- 10297 ((3- 2- NAPHTHALENEACETIC ACID, DIMETHYLAMINO)PROPYL)TRIPH 98% ENYL- PHOSPHONIUM BROMIDE, 12586 (+)-ANDROSTA-1,4-DIENE-3,17- 99% DIONE, 98% 13458 ((R)-(+)-2,2'- 963 (+)-ARABINOGALACTAN BIS(DIPHENYLPHOSPHINO)-1,1'-
    [Show full text]
  • Polyphenols in Cancer Prevention: New Insights (Review)
    INTERNATIONAL JOURNAL OF FUNCTIONAL NUTRITION 1: 9, 2020 Polyphenols in cancer prevention: New insights (Review) GIUSI BRIGUGLIO1, CHIARA COSTA2, MANUELA POLLICINO1, FEDERICA GIAMBÒ1, STEFANIA CATANIA1 and CONCETTINA FENGA1 1Department of Biomedical and Dental Sciences and Morpho‑functional Imaging, Occupational Medicine Section, and 2Department of Clinical and Experimental Medicine, University of Messina, I‑98125 Messina, Italy Received July 30, 2020; Accepted September 21, 2020 DOI:10.3892/ijfn.2020.9 Abstract. A huge volume of literature data suggests that a diet Contents rich in fruits and vegetables, mostly due to the contribution of natural polyphenols, could reduce the incidence of specific 1. Introduction cancers. Resveratrol, epigallocatechin gallate and curcumin 2. Literature search are among the most extensively studied polyphenols: The 3. Classification of polyphenols majority of the effects attributed to these compounds are 4. Prostate cancer linked to their antioxidant and anti‑inflammatory properties. 5. Colon cancer The multiple mechanisms involved include the modulation 6. Breast cancer of molecular events and signaling pathways associated with 7. Lung cancer cell survival, proliferation, differentiation, migration, angio‑ 8. Bladder cancer genesis, hormonal activities, detoxification enzymes and 9. Skin cancer immune responses. Notwithstanding their promising role in 10. Pancreatic cancer cancer prevention and treatment, polyphenols often have a 11. Leukemia poor bioavailability when administered as pure active prin‑
    [Show full text]
  • Thyroid-Modulating Activities of Olive and Its Polyphenols: a Systematic Review
    nutrients Review Thyroid-Modulating Activities of Olive and Its Polyphenols: A Systematic Review Kok-Lun Pang 1,† , Johanna Nathania Lumintang 2,† and Kok-Yong Chin 1,* 1 Department of Pharmacology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Jalan Yaacob Latif, Bandar Tun Razak, Cheras 56000, Kuala Lumpur, Malaysia; [email protected] 2 Faculty of Applied Sciences, UCSI University Kuala Lumpur Campus, Jalan Menara Gading, Taman Connaught, Cheras 56000, Kuala Lumpur, Malaysia; [email protected] * Correspondence: [email protected]; Tel.: +60-3-91459573 † These authors contributed equally to this work. Abstract: Olive oil, which is commonly used in the Mediterranean diet, is known for its health benefits related to the reduction of the risks of cancer, coronary heart disease, hypertension, and neurodegenerative disease. These unique properties are attributed to the phytochemicals with potent antioxidant activities in olive oil. Olive leaf also harbours similar bioactive compounds. Several studies have reported the effects of olive phenolics, olive oil, and leaf extract in the modulation of thyroid activities. A systematic review of the literature was conducted to identify relevant studies on the effects of olive derivatives on thyroid function. A comprehensive search was conducted in October 2020 using the PubMed, Scopus, and Web of Science databases. Cellular, animal, and human studies reporting the effects of olive derivatives, including olive phenolics, olive oil, and leaf extracts on thyroid function were considered. The literature search found 445 articles on this topic, but only nine articles were included based on the inclusion and exclusion criteria. All included articles were animal studies involving the administration of olive oil, olive leaf extract, or olive pomace residues orally.
    [Show full text]
  • Oleuropein Or Rutin Consumption Decreases the Spontaneous Development of Osteoarthritis in the Hartley Guinea Pig
    Osteoarthritis and Cartilage 23 (2015) 94e102 Oleuropein or rutin consumption decreases the spontaneous development of osteoarthritis in the Hartley guinea pig M.-N. Horcajada y a, C. Sanchez z a, F. Membrez Scalfo y, P. Drion x, F. Comblain z, * S. Taralla k, A.-F. Donneau ¶, E.A. Offord y, Y. Henrotin z # y Nestle Research Center, Nutrition and Health Research, Vers-Chez-les-Blanc, Lausanne 26 1000, Switzerland z Bone and Cartilage Research Unit, Arthropole,^ University of Liege, Institute of Pathology, CHU Sart-Tilman, 4000 Liege, Belgium x GIGA CHU Animal Facility, University of Liege, 4000 Liege, Belgium k Artialis SA, 4000 Liege Belgium ¶ Public Health Department, University of Liege, 4000 Liege, Belgium # Department of Physical Therapy and Rehabilitation, Princess Paola Hospital, Marche-en-famenne, Belgium article info summary Article history: Objective: To assess the potential protective effects of three polyphenols oleuropein, rutin and curcumin, Received 10 February 2014 on joint ageing and osteoarthritis (OA) development. Accepted 28 August 2014 Design: Sixty 4-week-old DunkineHartley guinea pigs were randomized into four groups and received daily during 31 weeks either standard guinea pig diet (control group) or a standard guinea pig diet Keywords: enriched with oleuropein (0.025%), rutin (0.5%) or rutin/curcumin (0.5%/0.25%) association. Biomarkers Osteoarthritis of OA (Coll2-1, Coll2-1NO2, Fib3-1, Fib3-2, ARGS), as well as inflammation prostaglandin E2 (PGE2) were Phytonutrients quantified in the serum. Histological assessments of knee cartilage and synovial membrane were per- Oleuropein fi Rutin formed at week 4 ( ve young reference guinea pigs) and week 35.
    [Show full text]
  • Polyphenols and IUGR Pregnancies: Effects of the Antioxidant Hydroxytyrosol on Brain Neurochemistry and Development in a Porcine Model
    antioxidants Article Polyphenols and IUGR Pregnancies: Effects of the Antioxidant Hydroxytyrosol on Brain Neurochemistry and Development in a Porcine Model Natalia Yeste 1 , Daniel Valent 1, Laura Arroyo 1, Marta Vázquez-Gómez 2 , Consolación García-Contreras 2, Martí Pumarola 3 , Antonio González-Bulnes 2,4,5 and Anna Bassols 1,* 1 Departament de Bioquímica i Biologia Molecular, Facultat de Veterinària, Universitat Autònoma de Barcelona, Cerdanyola del Vallès, 08193 Barcelona, Spain; [email protected] (N.Y.); [email protected] (D.V.); [email protected] (L.A.) 2 Faculty of Veterinary Sciences, UCM, Ciudad Universitaria s/n., 28040 Madrid, Spain; [email protected] (M.V.-G.); [email protected] (C.G.-C.); [email protected] (A.G.-B.) 3 Unitat de Patologia Murina i Comparada, Departament de Medicina i Cirurgia Animals, Facultat de Veterinària, Universitat Autònoma de Barcelona, Cerdanyola del Vallès, 08193 Barcelona, Spain; [email protected] 4 Comparative Physiology Group, INIA, Avda, Puerta de Hierro s/n., 28040 Madrid, Spain 5 Departamento de Produccion y Sanidad Animal, Facultad de Veterinaria, Universidad Cardenal Herrera-CEU, CEU Universities, Tirant lo Blanc, 7, Alfara del Patriarca, 46115 Valencia, Spain * Correspondence: [email protected] Citation: Yeste, N.; Valent, D.; Arroyo, L.; Vázquez-Gómez, M.; Abstract: Supplementation of a mother’s diet with antioxidants, such as hydroxytyrosol (HTX), García-Contreras, C.; Pumarola, M.; has been proposed to ameliorate the adverse phenotypes of fetuses at risk of intrauterine growth González-Bulnes, A.; Bassols, A. restriction. In the present study, sows were treated daily with or without 1.5 mg of HTX per kilogram Polyphenols and IUGR Pregnancies: of feed from day 35 of pregnancy (at 30% of total gestational period), and individuals were sampled Effects of the Antioxidant Hydroxytyrosol on Brain at three different ages: 100-day-old fetuses and 1-month- and 6-month-old piglets.
    [Show full text]
  • Bioconversion Using Lactic Acid Bacteria: Ginsenosides, GABA, and Phenolic Compounds Na-Kyoung Lee1 and Hyun-Dong Paik1,2*
    J. Microbiol. Biotechnol. (2017), 27(5), 869–877 https://doi.org/10.4014/jmb.1612.12005 Research Article Review jmb Bioconversion Using Lactic Acid Bacteria: Ginsenosides, GABA, and Phenolic Compounds Na-Kyoung Lee1 and Hyun-Dong Paik1,2* 1Department of Food Science and Biotechnology of Animal Resources, 2Bio/Molecular Informatics Center, Konkuk University, Seoul 05029, Republic of Korea Received: December 14, 2016 Revised: February 24, 2017 Lactic acid bacteria (LAB) are used as fermentation starters in vegetable and dairy products Accepted: March 15, 2017 and influence the pH and flavors of foods. For many centuries, LAB have been used to manufacture fermented foods; therefore, they are generally regarded as safe. LAB produce various substances, such as lactic acid, β-glucosidase, and β-galactosidase, making them First published online useful as fermentation starters. Existing functional substances have been assessed as March 15, 2017 fermentation substrates for better component bioavailability or other functions. Representative *Corresponding author materials that were bioconverted using LAB have been reported and include minor Phone: +82-2-2049-6011; ginsenosides, γ-aminobutyric acid, equol, aglycones, bioactive isoflavones, genistein, and Fax: +82-2-455-3082; daidzein, among others. Fermentation mainly involves polyphenol and polysaccharide E-mail: [email protected] substrates and is conducted using bacterial strains such as Streptococcus thermophilus, Lactobacillus plantarum, and Bifidobacterium sp. In this review, we summarize recent studies of pISSN 1017-7825, eISSN 1738-8872 bioconversion using LAB and discuss future directions for this field. Copyright© 2017 by The Korean Society for Microbiology Keywords: Lactic acid bacteria, fermentation, bioconversion, phenolic compound, β-glucosidase and Biotechnology Introduction be selected for their potential nutritional benefits.
    [Show full text]
  • Molecularly Imprinted Polymers Combined with Electrochemical Sensors for Food Contaminants Analysis
    molecules Review Molecularly Imprinted Polymers Combined with Electrochemical Sensors for Food Contaminants Analysis Dounia Elfadil 1,2, Abderrahman Lamaoui 2 , Flavio Della Pelle 1 , Aziz Amine 2,* and Dario Compagnone 1,* 1 Faculty of Bioscience and Technology for Food, Agriculture and Environment, University of Teramo, Via Renato Balzarini 1, 64100 Teramo, Italy; [email protected] (D.E.); [email protected] (F.D.P.) 2 Laboratory of Process Engineering and Environment, Faculty of Sciences and Techniques, Hassan II University of Casablanca, Mohammedia 28810, Morocco; [email protected] * Correspondence: [email protected] (A.A.); [email protected] (D.C.) Abstract: Detection of relevant contaminants using screening approaches is a key issue to ensure food safety and respect for the regulatory limits established. Electrochemical sensors present several advantages such as rapidity; ease of use; possibility of on-site analysis and low cost. The lack of selectivity for electrochemical sensors working in complex samples as food may be overcome by coupling them with molecularly imprinted polymers (MIPs). MIPs are synthetic materials that mimic biological receptors and are produced by the polymerization of functional monomers in presence of a target analyte. This paper critically reviews and discusses the recent progress in MIP-based electrochemical sensors for food safety. A brief introduction on MIPs and electrochemical sensors is given; followed by a discussion of the recent achievements for various MIPs-based electrochemical sensors for food contaminants analysis. Both electropolymerization and chemical synthesis of MIP- Citation: Elfadil, D.; Lamaoui, A.; based electrochemical sensing are discussed as well as the relevant applications of MIPs used in Della Pelle, F.; Amine, A.; sample preparation and then coupled to electrochemical analysis.
    [Show full text]
  • Analytical Reference Standards
    Cerilliant Quality ISO GUIDE 34 ISO/IEC 17025 ISO 90 01:2 00 8 GM P/ GL P Analytical Reference Standards 2 011 Analytical Reference Standards 20 811 PALOMA DRIVE, SUITE A, ROUND ROCK, TEXAS 78665, USA 11 PHONE 800/848-7837 | 512/238-9974 | FAX 800/654-1458 | 512/238-9129 | www.cerilliant.com company overview about cerilliant Cerilliant is an ISO Guide 34 and ISO 17025 accredited company dedicated to producing and providing high quality Certified Reference Standards and Certified Spiking SolutionsTM. We serve a diverse group of customers including private and public laboratories, research institutes, instrument manufacturers and pharmaceutical concerns – organizations that require materials of the highest quality, whether they’re conducing clinical or forensic testing, environmental analysis, pharmaceutical research, or developing new testing equipment. But we do more than just conduct science on their behalf. We make science smarter. Our team of experts includes numerous PhDs and advance-degreed specialists in science, manufacturing, and quality control, all of whom have a passion for the work they do, thrive in our collaborative atmosphere which values innovative thinking, and approach each day committed to delivering products and service second to none. At Cerilliant, we believe good chemistry is more than just a process in the lab. It’s also about creating partnerships that anticipate the needs of our clients and provide the catalyst for their success. to place an order or for customer service WEBSITE: www.cerilliant.com E-MAIL: [email protected] PHONE (8 A.M.–5 P.M. CT): 800/848-7837 | 512/238-9974 FAX: 800/654-1458 | 512/238-9129 ADDRESS: 811 PALOMA DRIVE, SUITE A ROUND ROCK, TEXAS 78665, USA © 2010 Cerilliant Corporation.
    [Show full text]
  • Development and Validation of an Analytical Method for Quantification of Dopamine Metabolism in Plasma Samples by LC-MS/MS
    Ana Sofia Abrantes Dias Development and validation of an analytical method for quantification of dopamine metabolism in plasma samples by LC-MS/MS Dissertação apresentada para provas de Mestrado em Química Forense Doutor Bruno José Fernandes Oliveira Manadas Professora Doutora Maria João Moreno junho 2017 Universidade de Coimbra Este projeto foi realizado no grupo Life Sciences Mass Spectrometry do Centro de Neurociências e Biologia Celular (Universidade de Coimbra, Portugal), orientado pelo Doutor Bruno Manadas. O trabalho foi financiado pela Fundação para a Ciência e Tecnologia (FCT), Portugal, com os projetos PTDC/SAU-NEU/103728/2008, PTDC/NEU-NMC/0205/2012, PTDC/NEU-SCC/7051/2014 e UID/NEU/04539/2013, e co-financiado pelo Programa COMPETE 2020 (Programa Operacional Fatores de Competitividade), pelo QREN, a União Europeia (FEDER – Fundo Europeu de Desenvolvimento Regional), e pela Rede Nacional de Espectrometria de Massa (RNEM), sob o contracto REDE/1506/REM/2005. The present work was performed in the Life Sciences Mass Spectrometry group of Center for Neuroscience and Cell Biology (University of Coimbra, Portugal), and under scientific guidance of Doctor Bruno Manadas. The work was supported by Fundação para a Ciência e Tecnologia (FCT), Portugal, projects references PTDC/SAU-NEU/103728/2008, PTDC/NEU-NMC/0205/2012, PTDC/NEU- SCC/7051/2014 and UID/NEU/04539/2013, and cofinanced by "COMPETE 2020 Programa Operacional Fatores de Competitividade, QREN, the European Union (FEDER – Fundo Europeu de Desenvolvimento Regional) and by The National Mass Spectrometry Network (RNEM) under contract REDE/1506/REM/2005. Agradecimentos A realização desta tese não teria sido possível sem o contributo, estímulo e empenho de várias pessoas e, como tal, gostaria de expressar toda a minha gratidão a todos os que, direta ou indiretamente contribuíram para que esta tarefa fosse possível.
    [Show full text]
  • Natural Compounds and Neuroprotection: Mechanisms of Action and Novel Delivery Systems ELENI BAGLI 1,2 , ANNA GOUSSIA 3, MARILITA M
    in vivo 30 : 535-548 (2016) Review Natural Compounds and Neuroprotection: Mechanisms of Action and Novel Delivery Systems ELENI BAGLI 1,2 , ANNA GOUSSIA 3, MARILITA M. MOSCHOS 4, NIKI AGNANTIS 3 and GEORGIOS KITSOS 2 1Institute of Molecular Biology and Biotechnology - FORTH, Division of Biomedical Research, Ioannina, Greece; 2Department of Ophthalmology, University of Ioannina, Ioannina, Greece; 3Department of Pathology, University of Ioannina, Ioannina, Greece; 4Department of Ophthalmology, University of Athens, Athens, Greece Abstract. Neurodegeneration characterizes pathologic pathological events, including oxidative stress, mitochondrial conditions, ranging from Alzheimer’s disease to glaucoma, dysfunction, inflammation and protein aggregation (2, 3). with devastating social and economic effects. It is a The increasing knowledge of the cellular and molecular complex process implicating a series of molecular and events underlying the degenerative process has greatly cellular events, such as oxidative stress, mitochondrial stimulated research for identifying compounds capable of dysfunction, protein misfolding, excitotoxicity and stopping or, at least, slowing the progress of neural inflammation. Natural compounds, because of their broad deterioration. spectrum of pharmacological and biological activities, Natural compounds are complex chemical multiple-target could be possible candidates for the management of such molecules found mainly in plants and microorganisms (4). multifactorial morbidities. However, their therapeutic These agents
    [Show full text]
  • Oleuropein Alleviates Gestational Diabetes Mellitus by Activating AMPK Signaling
    ID: 20-0466 10 1 Z Zhang, H Zhao et al. Oleuropein activates AMPK 10:1 45–53 signaling RESEARCH Oleuropein alleviates gestational diabetes mellitus by activating AMPK signaling Zhiwei Zhang*, Hui Zhao* and Aixia Wang Department of Obstetrics and Gynecology, Liaocheng People’s Hospital, Liaocheng, Shandong, China Correspondence should be addressed to A Wang: [email protected] *(Z Zhang and H Zhao contributed equally to this work) Abstract Background: Gestational diabetes mellitus (GDM) has a high incidence rate among Key Words pregnant women. The objective of the study was to assess the effect of plant-derived f oleuropein oleuropein in attenuating inflammatory and oxidative stress of GDM. f gestational diabetes Methods: Oleuropein was administered to GDM mice at the doses of 5 or 10 mg/kg/ mellitus day. Body weight, blood glucose, insulin and hepatic glycogen levels were recorded. To f oxidative stress evaluate the effect of oleuropein in reducing oxidative stress, ELISA was used to measure f inflammation the hepatic oxidative stress markers. The inflammation levels of GDM mice were f AMPK signaling evaluated by measuring serum levels of IL-6 and TNF-α by ELISA and mRNA levels of IL-1β, TNF-α and IL-6 by real-time PCR (RT-PCR). The AMP-activated protein kinase (AMPK) signaling pathway was assessed by Western blot. Gestational outcome was analyzed through comparing litter size and birth weight. Results: Oleuropein attenuated the elevated body weight of GDM mice and efficiently reduced blood glucose, insulin and hepatic glycogen levels. Oxidative stress and inflammation were alleviated by oleuropein treatment. The AMPK signaling was activated by oleuropein in GDM mice.
    [Show full text]
  • Effect of Urtica Dioica on Memory Dysfunction and Hypoalgesia in an Experimental Model of Diabetic Neuropathy
    See discussions, stats, and author profiles for this publication at: https://www.researchgate.net/publication/255690725 Effect of Urtica dioica on memory dysfunction and hypoalgesia in an experimental model of diabetic neuropathy Article in Neuroscience Letters · July 2013 DOI: 10.1016/j.neulet.2013.07.029 · Source: PubMed CITATIONS READS 14 118 2 authors: Sita Sharan Patel Udayabanu Malairaman Sagar Institute of Research and Technology Jaypee University of Information Technology 26 PUBLICATIONS 311 CITATIONS 28 PUBLICATIONS 221 CITATIONS SEE PROFILE SEE PROFILE Some of the authors of this publication are also working on these related projects: Investigation of the effect of scopoletin on neurological alterations during streptozotocin induced chronic diabetes View project Computational approach for investigation of genes and proteins associated to Alzheimer's Disease for early diagnosis of the disease. View project All content following this page was uploaded by Sita Sharan Patel on 06 August 2015. The user has requested enhancement of the downloaded file. This article appeared in a journal published by Elsevier. The attached copy is furnished to the author for internal non-commercial research and education use, including for instruction at the authors institution and sharing with colleagues. Other uses, including reproduction and distribution, or selling or licensing copies, or posting to personal, institutional or third party websites are prohibited. In most cases authors are permitted to post their version of the article (e.g. in Word
    [Show full text]